Clinical Trial Update: SGLT2i Improve Left Atrial Function in Patients With Paroxysmal Atrial Fibrillation, Hypertension and Abnormal Glucose Metabolism [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating SGLT2 inhibitors in patients with paroxysmal atrial fibrillation and hypertension (and abnormal glucose metabolism) is recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Hypertension

Drugs mentioned

• SGLT2 inhibitor

Snippet

Sponsor: Huashan Hospital | Conditions: Atrial Fibrillation (AF), Hypertension | Phase 2 | Status: RECRUITING